glp-1 lupus Glucagon-like peptide-1 receptor agonist and nephritis in systemic lupus erythematosus with type 2 diabetes GLP-1RA Cuts Cardiovascular and Kidney

Remove the sterile cap from the vial and wipe the top of the vial with an alcohol swab

This accelerated timeline means reaching goal weights faster and spending less time in the challenging early treatment phase

Surrogacy involves regular appointments, injections, and blood draws

What else changes

6 CT-868, an investigational, once-daily, subcutaneously injected dual GLP-1/GIP receptor agonist currently in Phase II with the potential to be a first in class treatment for glycaemic control as an adjunct to insulin in patients living with type 1 diabetes

Abdominal injection absorbs fastest, thigh is slower with potentially fewer side effects, and the upper arm falls in between